Kane Biotech Inc. (TSXV:KNE)
Canada · Delayed Price · Currency is CAD 0.0350
0.00 (0.00%)
May 20, 2026, 12:16 PM EST
Kane Biotech Market Cap
Kane Biotech has a market cap or net worth of CAD 6.36 million as of May 21, 2026. Its market cap has decreased by -64.24% in one year.
Market Cap
6.36M
Enterprise Value
7.77M
Revenue
427.87K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since May 20, 2003, Kane Biotech's market cap has increased from 1.03M to 6.36M, an increase of 518.98%. That is a compound annual growth rate of 8.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 6.36M | -12.25% |
| Dec 30, 2025 | 7.25M | -52.04% |
| Dec 31, 2024 | 15.13M | 43.41% |
| Dec 29, 2023 | 10.55M | -6.12% |
| Dec 30, 2022 | 11.23M | -36.87% |
| Dec 31, 2021 | 17.80M | 17.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hemostemix | 11.87M |
| Glow Lifetech | 10.58M |
| Marvel Biosciences | 10.08M |
| COSCIENS Biopharma | 7.90M |
| Innovotech | 7.35M |
| Quest PharmaTech | 6.77M |
| MindBio Therapeutics | 6.55M |
| Aptose Biosciences | 5.95M |